BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M; Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45:471-7. [DOI: 10.1007/s00535-010-0221-9] [Cited by in Crossref: 188] [Cited by in F6Publishing: 155] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 You MW, Kim JH, Byun JH, Kim HJ, Lee SS, Kim MH, Lee MG. Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors. Eur Radiol 2014;24:1039-48. [PMID: 24573568 DOI: 10.1007/s00330-014-3127-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
2 Noguchi K, Nakai Y, Mizuno S, Hirano K, Kanai S, Suzuki Y, Inokuma A, Sato T, Hakuta R, Ishigaki K, Saito K, Saito T, Hamada T, Takahara N, Kogure H, Isayama H, Koike K. Role of Endoscopic Ultrasonography-Guided Fine Needle Aspiration/Biopsy in the Diagnosis of Autoimmune Pancreatitis. Diagnostics (Basel) 2020;10:E954. [PMID: 33203118 DOI: 10.3390/diagnostics10110954] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dumas-Campagna M, Bouchard S, Soucy G, Bouin M. IgG4-Related Esophageal Disease Presenting as Esophagitis Dissecans Superficialis With Chronic Strictures. J Clin Med Res 2014;6:295-8. [PMID: 24883156 DOI: 10.14740/jocmr1845w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961-970. [PMID: 24639058 DOI: 10.1007/s00535-014-0945-z] [Cited by in Crossref: 140] [Cited by in F6Publishing: 114] [Article Influence: 17.5] [Reference Citation Analysis]
5 Matsubayashi H, Kakushima N, Takizawa K, Tanaka M, Imai K, Hotta K, Ono H. Diagnosis of autoimmune pancreatitis. World J Gastroenterol 2014; 20(44): 16559-16569 [PMID: 25469024 DOI: 10.3748/wjg.v20.i44.16559] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
6 Ueda K, Ikeda K, Ogawa K, Sukegawa M, Sano T, Kimura S, Suzuki O, Hashimoto Y, Takeishi Y. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report. J Med Case Rep 2016;10:236. [PMID: 27557810 DOI: 10.1186/s13256-016-1009-1] [Reference Citation Analysis]
7 Okazaki K, Uchida K, Sumimoto K, Mitsuyama T, Ikeura T, Takaoka M. Autoimmune pancreatitis: pathogenesis, latest developments and clinical guidance. Ther Adv Chronic Dis 2014;5:104-11. [PMID: 24790726 DOI: 10.1177/2040622314527120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
8 Monach PA. IgG4-related Disease: 2013 Update. Curr Treat Options Cardiovasc Med 2013;15:214-23. [PMID: 23392964 DOI: 10.1007/s11936-013-0232-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:67-71. [PMID: 21124087 DOI: 10.1097/bor.0b013e328341a240] [Cited by in Crossref: 161] [Cited by in F6Publishing: 58] [Article Influence: 14.6] [Reference Citation Analysis]
10 Arora Z, Chahal P. Comment re: "Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting". Pancreatology 2016;16:689-90. [PMID: 27329667 DOI: 10.1016/j.pan.2016.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, Tabeya T, Matsui M, Suzuki C, Takahashi H, Seki N, Himi T, Yamashita K, Noguchi H, Hasegawa T, Suzuki Y, Honda S, Abe T, Imai K, Shinomura Y. Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression. Rheumatology 2013;52:679-83. [DOI: 10.1093/rheumatology/kes358] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
12 Imazu H, Kanazawa K, Mori N, Ikeda K, Kakutani H, Sumiyama K, Hino S, Ang TL, Omar S, Tajiri H. Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma. Scand J Gastroenterol. 2012;47:853-860. [PMID: 22507131 DOI: 10.3109/00365521.2012.679686] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
13 Okazaki K, Uchida K, Ikeura T, Takaoka M. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J Gastroenterol. 2013;48:303-314. [PMID: 23417598 DOI: 10.1007/s00535-012-0744-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
14 López-serrano A, Crespo J, Pascual I, Salord S, Bolado F, del-Pozo-García AJ, Ilzarbe L, de-Madaria E, Moreno-osset E. Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: A multi-centre study. Pancreatology 2016;16:382-90. [DOI: 10.1016/j.pan.2016.02.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
15 Xin L, Meng QQ, Hu LH, Lin H, Pan J, Hao L, Liu PP, Qian W, Wang LW, Li ZS. Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China. Pancreas 2018;47:1110-4. [PMID: 30142120 DOI: 10.1097/MPA.0000000000001147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
16 Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, Homma N, Tsubata Y, Takahashi H, Ito T. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84:826-833. [PMID: 23698232 DOI: 10.1038/ki.2013.191] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 11.1] [Reference Citation Analysis]
17 Feydorova TI, Vinokurova LV, Dvoynikov SY, Mikheeva OM, Dudin GA, Akopova AO. [Clinical case of IgG4-related disease in a patient with Burkitt lymphoma]. Ter Arkh 2019;91:100-5. [PMID: 32598742 DOI: 10.26442/00403660.2019.07.000069] [Reference Citation Analysis]
18 Zaidan M, Ebbo M, Brochériou I, Ronco P, Schleinitz N, Boffa JJ. [IgG4-related disease and renal and urological involvement]. Nephrol Ther 2012;8:499-507. [PMID: 22480723 DOI: 10.1016/j.nephro.2012.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Bor R, Farkas K, Bálint A, Wittmann T, Nagy F, Tiszlavicz L, Molnár T, Szepes Z. [Autoimmune pancreatitis in a patient with ulcerative colitis simulating a pancreatic tumor]. Orv Hetil 2014;155:1000-4. [PMID: 24936576 DOI: 10.1556/OH.2014.29936] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 O’Reilly DA, Malde DJ, Duncan T, Rao M, Filobbos R. Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol 2014; 5(2): 71-81 [PMID: 24891978 DOI: 10.4291/wjgp.v5.i2.71] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
21 Beyer G, Schwaiger T, Lerch MM, Mayerle J. IgG4-related disease: a new kid on the block or an old aquaintance? United European Gastroenterol J 2014;2:165-72. [PMID: 25360299 DOI: 10.1177/2050640614532457] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
22 Proctor RD, Rofe CJ, Bryant TJ, Hacking CN, Stedman B. Autoimmune pancreatitis: an illustrated guide to diagnosis. Clin Radiol. 2013;68:422-432. [PMID: 23177083 DOI: 10.1016/j.crad.2012.08.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Woo CG, Yook JH, Kim AY, Kim J. IgG4-Related Disease Presented as a Mural Mass in the Stomach. J Pathol Transl Med. 2016;50:67-70. [PMID: 26420251 DOI: 10.4132/jptm.2015.07.28] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
24 Singh A, Singh V. IgG4-Related Sclerosing Cholangitis. Curr Hepatology Rep 2020;19:139-46. [DOI: 10.1007/s11901-020-00535-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Caputo C, Bazargan A, Mckelvie PA, Sutherland T, Su CS, Inder WJ. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy. Pituitary 2014;17:251-6. [DOI: 10.1007/s11102-013-0498-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
26 Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, Masseau A, Bernard F, Berthelot JM, Morel N. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66:86-96. [PMID: 23836437 DOI: 10.1002/acr.22058] [Cited by in Crossref: 112] [Cited by in F6Publishing: 95] [Article Influence: 14.0] [Reference Citation Analysis]
27 Maida M, Macaluso FS, Cabibbo G, Lo Re G, Alessi N. Progressive multi-organ expression of immunoglobulin G4-related disease: A case report. World J Hepatol 2013; 5(6): 336-339 [PMID: 23805359 DOI: 10.4254/wjh.v5.i6.336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
28 Yamamoto M, Nojima M, Takahashi H, Yokoyama Y, Ishigami K, Yajima H, Shimizu Y, Tabeya T, Matsui M, Suzuki C, Naishiro Y, Takano K, Himi T, Imai K, Shinomura Y. Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment. Rheumatology (Oxford) 2015;54:45-9. [PMID: 24907151 DOI: 10.1093/rheumatology/keu228] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
29 Xiang P, Zhang X, Wang C, Lang Y, Xu L, Huang L, Shen J, Feng ST. Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge. BMC Cancer. 2019;19:814. [PMID: 31419961 DOI: 10.1186/s12885-019-6027-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Cho MJ, Moon HS, Lee HS, Park JH, Kim JS, Kang SH, Lee ES, Kim SH, Sung JK, Lee BS, Jeong HY. Immunoglobulin G4-related disease in the stomach presenting as a gastric subepithelial tumor: Case report. Medicine (Baltimore) 2020;99:e22078. [PMID: 32899079 DOI: 10.1097/MD.0000000000022078] [Reference Citation Analysis]
31 Valero Liñán AS, Rueda Martínez JL, González Masiá JA, Miota de Llama JI, González Masegosa P. ¿Pancreatitis autoinmune o cáncer de páncreas? Cirugía Española 2016;94:415-7. [DOI: 10.1016/j.ciresp.2016.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Li A, Wang Y, Deng Z. Concurrent autoimmune pancreatitis and primary biliary cirrhosis: a rare case report and literature review. BMC Gastroenterol. 2014;14:10. [PMID: 24410827 DOI: 10.1186/1471-230X-14-10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Hart PA, Zen Y, Chari ST. Recent Advances in Autoimmune Pancreatitis. Gastroenterology 2015;149:39-51. [DOI: 10.1053/j.gastro.2015.03.010] [Cited by in Crossref: 139] [Cited by in F6Publishing: 102] [Article Influence: 19.9] [Reference Citation Analysis]
34 Watanabe A, Goto T, Kamo H, Komine R, Kuroki N, Sugase T, Takaya T, Koga R, Hojo H, Taniguchi S, Ibusuki K, Koga K. Resection of lesions in the ileum of patients with IgG4-related disease may ameliorate disease progression without steroid administration. Surg Case Rep 2018;4:148. [PMID: 30594958 DOI: 10.1186/s40792-018-0546-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Rousselin C, Pontana F, Puech P, Lambert M. Diagnostics différentiels des aortites inflammatoires. La Revue de Médecine Interne 2016;37:256-63. [DOI: 10.1016/j.revmed.2016.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Xin L, He YX, Zhu XF, Zhang QH, Hu LH, Zou DW, Jin ZD, Chang XJ, Zheng JM, Zuo CJ, Shao CW, Jin G, Liao Z, Li ZS. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. Hepatobiliary Pancreat Dis Int 2014;13:642-8. [PMID: 25475868 DOI: 10.1016/s1499-3872(14)60263-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
37 Shu HJ, Tan B, Xue HD, Yang AM, Qian JM. IgG4-related sclerosing cholangitis with autoimmune pancreatitis and periaortitis: case report and review of the literature. J Dig Dis. 2012;13:280-286. [PMID: 22500791 DOI: 10.1111/j.1751-2980.2012.00585.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
38 Deng H, Zhao S, Yue Y, Liu Y, Xu Y, Qian J, Ma X, Gao P, Yao X, Jiang X, Xu X, Jing Z, Wang Y, Pan L, Xue X. IgG4-related disease of pulmonary artery causing pulmonary hypertension. Medicine (Baltimore) 2018;97:e10698. [PMID: 29768335 DOI: 10.1097/MD.0000000000010698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Szepes Z, Dobra M, Góg C, Zábrák E, Makula É, Tiszlavicz L, Kiss T, Molnár T, Nagy F, Czakó L. Pancreatic cancer or autoimmune pancreatitis: endosonography as a diagnostic reviser. Orv Hetil. 2013;154:62-68. [PMID: 23291204 DOI: 10.1556/oh.2013.29513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Dong F, Chen QQ, Zhuang ZH, He QL, Wang FQ, Liu QC, Liu HK, Wang Y. Multiple gene mutations in patients with type 2 autoimmune pancreatitis and its clinical features. Cent Eur J Immunol 2014;39:77-82. [PMID: 26155104 DOI: 10.5114/ceji.2014.42129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
41 Wu W, Yao X, Lin C, Jin D, Wang D, Lou W, Qin X. Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy? Gastroenterol Res Pract 2014;2014:253471. [PMID: 24578705 DOI: 10.1155/2014/253471] [Reference Citation Analysis]
42 Matsubayashi H, Ishiwatari H, Imai K, Kishida Y, Ito S, Hotta K, Yabuuchi Y, Yoshida M, Kakushima N, Takizawa K, Kawata N, Ono H. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis. Int J Mol Sci. 2019;21. [PMID: 31905944 DOI: 10.3390/ijms21010257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Terzin V, Földesi I, Kovács L, Pokorny G, Wittmann T, Czakó L. Association between autoimmune pancreatitis and systemic autoimmune diseases. World J Gastroenterol 2012; 18(21): 2649-2653 [PMID: 22690073 DOI: 10.3748/wjg.v18.i21.2649] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
44 Sireesha Y, Uppin MS, Ganti S, Alugolu R, Mudumba VS, Bhattacharjee S, Neeharika ML, Bastia J, Kanikannan MA. A Series of Biopsy-proven Patients with Immunoglobulin G4-related Neurological Disease. Ann Indian Acad Neurol 2019;22:73-8. [PMID: 30692763 DOI: 10.4103/aian.AIAN_283_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Fan RY, Sheng JQ. Immunoglobulin G4-related autoimmune pancreatitis and sialadenitis: A case report. World J Gastroenterol 2015; 21(31): 9448-9452 [PMID: 26309373 DOI: 10.3748/wjg.v21.i31.9448] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Ng SH, Tay JS, Lai EL. IgG4-related disease: an atypical presentation of steroid-responsive renal mass. BMJ Case Rep 2021;14:e240611. [PMID: 34031075 DOI: 10.1136/bcr-2020-240611] [Reference Citation Analysis]
47 Kamisawa T, Tabata T, Hara S, Kuruma S, Chiba K, Kanno A, Masamune A, Shimosegawa T. Recent advances in autoimmune pancreatitis. Front Physiol. 2012;3:374. [PMID: 23060806 DOI: 10.3389/fphys.2012.00374] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
48 Suzuki D, Shimizu K, Tokushige K. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse. Pancreas 2018;47:412-7. [DOI: 10.1097/mpa.0000000000001007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Gupta N, Mathew J, Mohan H, Chowdhury SD, Kurien RT, Christopher DJ, Thangakunam B, Alexander M, Sivadasan A, Tamilarasi V, Valson AT, Gowri M, Kabeerdoss J, Danda D. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India. Rheumatol Int 2018;38:203-9. [DOI: 10.1007/s00296-017-3730-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
50 Fairweather J, Jawad AS. Immunoglobulin G4-related Retroperitoneal Fibrosis: A New Name for an Old Disease. Urology 2013;82:505-7. [DOI: 10.1016/j.urology.2013.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Yonenaga Y, Kushihata F, Watanabe J, Tohyama T, Inoue H, Sugita A, Takada Y. Localized 18F-fluorodeoxyglucose uptake at the pancreatic head during remission phase of autoimmune pancreatitis: A case report. Oncol Lett 2016;12:1801-5. [PMID: 27602112 DOI: 10.3892/ol.2016.4815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol. 2012;67:297-305. [PMID: 22119099 DOI: 10.1016/j.crad.2011.10.011] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
53 Goto N, Mimura J, Itani T, Hayashi M, Shimada Y, Matsumori T. Autoimmune pancreatitis complicated by gastric varices: A report of 3 cases. World J Gastroenterol 2012; 18(31): 4228-4232 [PMID: 22919259 DOI: 10.3748/wjg.v18.i31.4228] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
54 Yoon SB, Moon SH, Kim JH, Park JW, Kim SE, Kim MH. Determination of the duration of glucocorticoid therapy in type 1 autoimmune pancreatitis: A systematic review and meta-analysis. Pancreatology 2021:S1424-3903(21)00474-9. [PMID: 34090808 DOI: 10.1016/j.pan.2021.05.303] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Takuma K, Kamisawa T, Gopalakrishna R, Hara S, Tabata T, Inaba Y, Egawa N, Igarashi Y. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol 2012; 18(10): 1015-1020 [PMID: 22416175 DOI: 10.3748/wjg.v18.i10.1015] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
56 Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, Wang X, Liang Z, Zhang F, Li F, Zhang W, Zhu Z. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 2014;41:1624-34. [PMID: 24764034 DOI: 10.1007/s00259-014-2729-3] [Cited by in Crossref: 133] [Cited by in F6Publishing: 117] [Article Influence: 16.6] [Reference Citation Analysis]
57 Sah RP, Chari ST. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management. Curr Gastroenterol Rep. 2012;14:95-105. [PMID: 22350841 DOI: 10.1007/s11894-012-0246-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
58 Zhang J, Guo X, Li H, Shao X, Deng J, Liang Z, Zhang X, Feng J, Lin H, Qi X. A good response to steroid therapy in IgG4-related sclerosing cholangitis: a case report. Clin Exp Hepatol. 2018;4:205-209. [PMID: 30324147 DOI: 10.5114/ceh.2018.78126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460-1471. [PMID: 25481618 DOI: 10.1016/s0140-6736(14)60720-0] [Cited by in Crossref: 629] [Cited by in F6Publishing: 257] [Article Influence: 78.6] [Reference Citation Analysis]
60 Xu WS, Wang Y, Chen HJ, Wang WH, Lin SR, Chen J. Value of serum IgG4 in differential diagnosis of IgG4-related disease from other autoimmune diseases. Shijie Huaren Xiaohua Zazhi 2014; 22(31): 4884-4889 [DOI: 10.11569/wcjd.v22.i31.4884] [Reference Citation Analysis]
61 Takuma K, Kamisawa T, Igarashi Y. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol. 2011;23:80-87. [PMID: 21124090 DOI: 10.1097/BOR.0b013e3283412f60] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
62 Rohan A, Ravishankar B, Vishwanath S, Vankalakunti M, Kishore B, Ballal HS. IgG4 related renal disease: A wolf in sheep's clothing. Indian J Nephrol 2014;24:382-6. [PMID: 25484534 DOI: 10.4103/0971-4065.133022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
63 Kusuda T, Uchida K, Miyoshi H, Koyabu M, Satoi S, Takaoka M, Shikata N, Uemura Y, Okazaki K. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis. Pancreas. 2011;40:1120-1130. [PMID: 21926547 DOI: 10.1097/mpa.0b013e31821fc796] [Cited by in Crossref: 57] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
64 Buijs J, van Heerde MJ, Rauws EA, de Buy Wenniger LJM, Hansen BE, Biermann K, Verheij J, Vleggaar FP, Brink MA, Beuers UHW, Kuipers EJ, Bruno MJ, van Buuren HR. Comparable Efficacy of Low- Versus High-Dose Induction Corticosteroid Treatment in Autoimmune Pancreatitis. Pancreas 2014;43:261-7. [DOI: 10.1097/mpa.0000000000000044] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
65 Okazaki K, Tomiyama T, Mitsuyama T, Sumimoto K, Uchida K. Diagnosis and classification of autoimmune pancreatitis. Autoimmun Rev. 2014;13:451-458. [PMID: 24424184 DOI: 10.1016/j.autrev.2014.01.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
66 Hirano K, Tada M, Isayama H, Sasahira N, Umefune G, Akiyama D, Watanabe T, Saito T, Takagi K, Takahara N. Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study. J Clin Gastroenterol. 2016;50:331-337. [PMID: 26565969 DOI: 10.1097/MCG.0000000000000440] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
67 Yu Y, Lv L, Yin SL, Chen C, Jiang S, Zhou PZ. Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: A case report. World J Clin Cases 2022; 10(18): 6269-6276 [DOI: 10.12998/wjcc.v10.i18.6269] [Reference Citation Analysis]
68 Al-Dhahab H, McNabb-Baltar J, Al-Busafi S, Barkun AN. Immunoglobulin G4-related pancreatic and biliary diseases. Can J Gastroenterol 2013;27:523-30. [PMID: 24078937 DOI: 10.1155/2013/180461] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
69 Couderc A, Evesque L, Queyrel V, Sillard L, Gary A, Arno E, Moreau B, Guérin O. IgG4-related systemic disease: Report of a case in an elderly patient. European Geriatric Medicine 2012;3:317-9. [DOI: 10.1016/j.eurger.2012.03.013] [Reference Citation Analysis]
70 Şerifoğlu İ, Öz İİ, Üstündağ Y, İlikhan SU, Tokgöz Ö. Sequential Evaluation of Pancreato-Biliary Findings in a Case with IgG4-Associated Cholangiopathy and Autoimmune Pancreatitis during Corticosteroid Treatment. Balkan Med J 2016;33:458-61. [PMID: 27606144 DOI: 10.5152/balkanmedj.2016.15420] [Reference Citation Analysis]
71 Younger DS. Headaches and vasculitis. Neurol Clin 2014;32:321-62. [PMID: 24703534 DOI: 10.1016/j.ncl.2013.11.004] [Reference Citation Analysis]
72 Hong X, Sun Z, Li W, Chen Y, Gao Y, Su J, Wang Z, Cai Z, Li T, Zhang L, Liu X, Liu Y, He J, Li Z, Yu G. Comorbid diseases of IgG4-related sialadenitis in the head and neck region: Comorbidities of IgG4-RS in the Head and Neck. The Laryngoscope 2015;125:2113-8. [DOI: 10.1002/lary.25387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
73 Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L, Frulloni L, Go VL, Gress TM, Kim MH, Kawa S, Lee KT, Lerch MM, Liao WC, Löhr M, Okazaki K, Ryu JK, Schleinitz N, Shimizu K, Shimosegawa T, Soetikno R, Webster G, Yadav D, Zen Y, Chari ST. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771-6. [PMID: 23232048 DOI: 10.1136/gutjnl-2012-303617] [Cited by in Crossref: 351] [Cited by in F6Publishing: 274] [Article Influence: 39.0] [Reference Citation Analysis]
74 Masamune A, Nishimori I, Kikuta K, Tsuji I, Mizuno N, Iiyama T, Kanno A, Tachibana Y, Ito T, Kamisawa T, Uchida K, Hamano H, Yasuda H, Sakagami J, Mitoro A, Taguchi M, Kihara Y, Sugimoto H, Hirooka Y, Yamamoto S, Inui K, Inatomi O, Andoh A, Nakahara K, Miyakawa H, Hamada S, Kawa S, Okazaki K, Shimosegawa T; Research Committee of Intractable Pancreas Diseases in Japan. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut 2017;66:487-94. [PMID: 27543430 DOI: 10.1136/gutjnl-2016-312049] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 22.0] [Reference Citation Analysis]
75 Liu Y, Xue F, Yang J, Zhang Y. Immunoglobulin G4-related disease mimicking lymphoma in a Chinese patient. Rheumatol Int 2015;35:1749-52. [PMID: 25800963 DOI: 10.1007/s00296-015-3259-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
76 Higashioka K, Yoshida K, Oryoji K, Kamada K, Mizuki S, Tsukamoto H, Yokota E, Akashi K. A Case of Immunoglobulin G4-Related Disease with Extensive Multiorgan Involvements. Case Rep Rheumatol 2015;2015:392893. [PMID: 26101684 DOI: 10.1155/2015/392893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
77 Tirelli G, Gardenal N, Gatto A, Quatela E, Del Piero GC. Head and neck immunoglobulin G4 related disease: systematic review. J Laryngol Otol 2018;132:1046-50. [PMID: 30558692 DOI: 10.1017/S0022215118002153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
78 Perez Alamino R, Espinoza LR, Zea AH. The great mimicker: IgG4-related disease. Clin Rheumatol 2013;32:1267-73. [PMID: 23877485 DOI: 10.1007/s10067-013-2326-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
79 Buechter M, Klein CG, Kloeters C, Gerken G, Canbay A, Kahraman A. Diagnostic Dilemma in a Patient with Jaundice: How to Differentiate between Autoimmune Pancreatitis, Primary Sclerosing Cholangitis and Pancreas Carcinoma. Case Rep Gastroenterol. 2012;6:211-216. [PMID: 22649334 DOI: 10.1159/000338649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
80 Buechter M, Manka P, Heinemann FM, Lindemann M, Juntermanns B, Canbay A, Gerken G, Kahraman A. Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. Gastroenterol Res Pract 2017;2017:6126707. [PMID: 28348580 DOI: 10.1155/2017/6126707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
81 Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014;85:251-257. [PMID: 24107849 DOI: 10.1038/ki.2013.393] [Cited by in Crossref: 82] [Cited by in F6Publishing: 63] [Article Influence: 9.1] [Reference Citation Analysis]
82 Clendenon JN, Aranda-michel J, Krishna M, Taner CB, Willingham DL. Recurrent liver failure caused by IgG4 associated cholangitis. Annals of Hepatology 2011;10:562-4. [DOI: 10.1016/s1665-2681(19)31527-3] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
83 Okazaki K, Uchida K, Koyabu M, Miyoshi H, Ikeura T, Takaoka M. IgG4 cholangiopathy: current concept, diagnosis, and pathogenesis. J Hepatol. 2014;61:690-695. [PMID: 24768756 DOI: 10.1016/j.jhep.2014.04.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
84 Hirano K, Tada M, Isayama H, Sasahira N, Koike K. Significance of Measuring IgG and IgG4 During Follow-Up of Autoimmune Pancreatitis. Pancreas 2011;40:788-91. [DOI: 10.1097/mpa.0b013e3182156e32] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
85 Younger DS. Overview of the Vasculitides. Neurol Clin 2019;37:171-200. [PMID: 30952404 DOI: 10.1016/j.ncl.2019.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Thakur KT, Wilson MR. Chronic Meningitis. Continuum (Minneap Minn) 2018;24:1298-326. [PMID: 30273241 DOI: 10.1212/CON.0000000000000664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Shimizu K, Tahara J, Takayama Y, Akao J, Ajihara T, Nagao K, Shiratori K, Tokushige K. Assessment of the Rate of Decrease in Serum IgG4 Level of Autoimmune Pancreatitis Patients in Response to Initial Steroid Therapy as a Predictor of Subsequent Relapse. Pancreas 2016;45:1341-6. [PMID: 27171510 DOI: 10.1097/MPA.0000000000000633] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
88 Jalilian C, Prince HM, Mccormack C, Lade S, Cheah CY. IgG4-related disease with cutaneous manifestations treated with rituximab: Case report and literature review: A case of IgG4-related disease. Australasian Journal of Dermatology 2014;55:132-6. [DOI: 10.1111/ajd.12100] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
89 Obiorah I, Hussain A, Palese C, Azumi N, Benjamin S, Ozdemirli M. IgG4-related disease involving the esophagus: a clinicopathological study. Dis Esophagus. 2017;30:1-7. [PMID: 28881885 DOI: 10.1093/dote/dox091] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
90 Hermet M, Kémény J, Guettrot-imbert G, Delèvaux I, Aumaître O, André M. Maladie fibrosclérosante à IgG4. La Presse Médicale 2012;41:682-94. [DOI: 10.1016/j.lpm.2011.10.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
91 Nishikawa G, Nakamura K, Yamada Y, Yoshizawa T, Kato Y, Katsuda R, Zennami K, Tobiume M, Aoki S, Taki T, Honda N. Inflammatory pseudotumors of the kidney and the lung presenting as immunoglobulin G4-related disease: a case report. J Med Case Rep 2011;5:480. [PMID: 21943114 DOI: 10.1186/1752-1947-5-480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
92 Yoo JJ, Park JJ, Kang EH, Lee EB, Song YW, Go HJ, Jeon YK, Chung JH, Lee YJ. Risk factors for the recurrence of IgG4-related Sclerosing disease without autoimmune pancreatitis. J Clin Rheumatol 2011;17:392-4. [PMID: 21946471 DOI: 10.1097/RHU.0b013e31823262d5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 Kamisawa T, Ryu JK, Kim MH, Okazaki K, Shimosegawa T, Chung JB. Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea. Gut Liver. 2013;7:394-400. [PMID: 23898377 DOI: 10.5009/gnl.2013.7.4.394] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
94 Okazaki K, Uchida K, Miyoshi H, Ikeura T, Takaoka M, Nishio A. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol. 2011;41:126-138. [PMID: 21170607 DOI: 10.1007/s12016-010-8214-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
95 Ebbo M, Grados A, Daniel L, Vély F, Harlé JR, Pavic M, Schleinitz N. IgG4-related systemic disease: emergence of a new systemic disease? Literature review. Rev Med Interne. 2012;33:23-34. [PMID: 21955722 DOI: 10.1016/j.revmed.2011.08.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
96 Pezzilli R. Immunosuppressive drugs for the treatment of autoimmune pancreatitis. Immunotherapy 2014;6:477-83. [DOI: 10.2217/imt.14.20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Maruyama M, Watanabe T, Kanai K, Oguchi T, Asano J, Ito T, Muraki T, Hamano H, Arakura N, Uehara T. Extracorporeal shock wave lithotripsy treatment of pancreatic stones complicated with advanced stage autoimmune pancreatitis. BMC Gastroenterol. 2015;15:28. [PMID: 25887404 DOI: 10.1186/s12876-015-0255-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
98 Ginat DT, Freitag SK, Kieff D, Grove A, Fay A, Cunnane M, Moonis G. Radiographic patterns of orbital involvement in IgG4-related disease. Ophthalmic Plast Reconstr Surg 2013;29:261-6. [PMID: 23645355 DOI: 10.1097/IOP.0b013e31829165ad] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
99 Dy RV, Atlas SA. So many organs, 1 diagnosis: IgG4-related disease. Am J Med 2014;127:195-7. [PMID: 24361210 DOI: 10.1016/j.amjmed.2013.12.008] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Nagpal SJS, Sharma A, Chari ST. Autoimmune Pancreatitis. Am J Gastroenterol. 2018;113:1301. [PMID: 29910463 DOI: 10.1038/s41395-018-0146-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
101 Cai YI, Li HZ, Zhang YS. IgG4-related inflammatory pseudotumor of the kidney mimicking renal cell carcinoma: A case report. Oncol Lett. 2016;11:3438-3440. [PMID: 27123131 DOI: 10.3892/ol.2016.4408] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
102 Gong PL, Liu TT, Shen XZ. Differentiation of autoimmune pancreatitis with pancreatic carcinoma remains a challenge to physicians. J Dig Dis. 2012;13:267-273. [PMID: 22500789 DOI: 10.1111/j.1751-2980.2012.00582.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
103 Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut 2013;62:1373-80. [PMID: 23749606 DOI: 10.1136/gutjnl-2012-304224] [Cited by in Crossref: 130] [Cited by in F6Publishing: 99] [Article Influence: 14.4] [Reference Citation Analysis]
104 Nizar AH, Toubi E. IgG4-related disease: case report and literature review. Auto Immun Highlights 2015;6:7-15. [PMID: 26216362 DOI: 10.1007/s13317-015-0069-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
105 Saavedra-perez D, Vaquero EC, Ayuso JR, Fernandez-cruz L. Pancreatitis autoinmune: un dilema quirúrgico. Cirugía Española 2014;92:645-53. [DOI: 10.1016/j.ciresp.2014.01.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
106 Yamauchi H, Satoh H, Yamashita T, Shinshi Y, Kikuchi K, Sasaki S, Matsui Y. Immunoglobulin G4-Related Disease of the Heart Causing Aortic Regurgitation and Heart Block. The Annals of Thoracic Surgery 2013;95:e151-3. [DOI: 10.1016/j.athoracsur.2012.11.057] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
107 Zen Y, Bogdanos DP, Kawa S. Type 1 autoimmune pancreatitis. Orphanet J Rare Dis. 2011;6:82. [PMID: 22151922 DOI: 10.1186/1750-1172-6-82] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
108 González-Moreno J, Losada López I, Ortego Centeno N. [IgG4-related disease]. Med Clin (Barc) 2015;145:539-44. [PMID: 25726306 DOI: 10.1016/j.medcli.2014.12.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Smit WL, Culver EL, Chapman RW. New Thoughts on Immunoglobulin G4–Related Sclerosing Cholangitis. Clinics in Liver Disease 2016;20:47-65. [DOI: 10.1016/j.cld.2015.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
110 Kosugi S, Okada M, Iwata K, Hasegawa S. Immunoglobulin G4-related disease of the thickened aortic valve extending to the left ventricular outflow tract causing severe aortic regurgitation and complete atrioventricular block: a case report. Eur Heart J Case Rep 2018;2:yty087. [PMID: 31020164 DOI: 10.1093/ehjcr/yty087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Zhang W, Glaze JH, Wynne D. Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review. CEN Case Rep 2018;7:137-42. [PMID: 29388171 DOI: 10.1007/s13730-018-0311-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
112 Okazaki K, Kawa S, Kamisawa T, Ikeura T, Itoi T, Ito T, Inui K, Irisawa A, Uchida K, Ohara H, Kubota K, Kodama Y, Shimizu K, Tonozuka R, Nakazawa T, Nishino T, Notohara K, Fujinaga Y, Masamune A, Yamamoto H, Watanabe T, Nishiyama T, Kawano M, Shiratori K, Shimosegawa T, Takeyama Y; Members of the Research Committee for IgG4-related Disease supported by the Ministry of Health, Labour, Welfare of Japan, Japan Pancreas Society. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020. J Gastroenterol 2022. [PMID: 35192048 DOI: 10.1007/s00535-022-01857-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
113 De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, Rizzo MI, Greco A. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res 2017;65:386-94. [DOI: 10.1007/s12026-016-8863-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
114 Brito-zerón P, Bosch X, Ramos-casals M, Stone JH. IgG4-related disease: Advances in the diagnosis and treatment. Best Practice & Research Clinical Rheumatology 2016;30:261-78. [DOI: 10.1016/j.berh.2016.07.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
115 Kamisawa T, Takuma K, Hara S, Tabata T, Kuruma S, Inaba Y, Gopalakrishna R, Egawa N, Itokawa F, Itoi T. Management strategies for autoimmune pancreatitis. Expert Opin Pharmacother. 2011;12:2149-2159. [PMID: 21711086 DOI: 10.1517/14656566.2011.595710] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
116 Nithyashree N, Rajagopalan S, Annigeri RA, Mani R. Immunoglobulin G4 related tubulointerstitial nephritis. Indian J Nephrol 2015;25:303-6. [PMID: 26628798 DOI: 10.4103/0971-4065.152725] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Nakamura A, Ozawa M, Watanabe T, Ito T, Muraki T, Hamano H, Koinuma M, Kawa S. Predictive Factors for Autoimmune Pancreatitis Relapse After 3 Years of Maintenance Therapy. Pancreas 2018;47:1337-43. [PMID: 30286015 DOI: 10.1097/MPA.0000000000001173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
118 Kubota K, Kamisawa T, Okazaki K, Kawa S, Hirano K, Hirooka Y, Uchida K, Shiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Shimosegawa T, Takeyama Y, Chiba T. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. J Gastroenterol. 2017;52:955-964. [PMID: 28062947 DOI: 10.1007/s00535-016-1302-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 9.4] [Reference Citation Analysis]
119 Luiz HV, Gonçalves D, Silva TN, Nascimento I, Ribeiro A, Mafra M, Manita I, Portugal J. IgG4-related Hashimoto's thyroiditis--a new variant of a well known disease. Arq Bras Endocrinol Metabol 2014;58:862-8. [PMID: 25465611 DOI: 10.1590/0004-2730000003283] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
120 Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Republished: recent advances in autoimmune pancreatitis: type 1 and type 2. Postgrad Med J. 2014;90:18-25. [PMID: 24336310 DOI: 10.1136/postgradmedj-2012-304224rep] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
121 Smyk DS, Rigopoulou EI, Koutsoumpas AL, Kriese S, Burroughs AK, Bogdanos DP. Autoantibodies in autoimmune pancreatitis. Int J Rheumatol. 2012;94:831. [PMID: 22844291 DOI: 10.1155/2012/940831] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
122 Najari BB, Robinson BD, Paget SA, Paduch DA. Clinical, Radiographic, and Pathologic Description of IgG4-related Perivasal Fibrosis: A Previously Undescribed Etiology of Chronic Orchialgia. Urology 2014;84:748-50. [DOI: 10.1016/j.urology.2014.06.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Gopalakrishnan N, Abraham A, Balasubramaniyan T, Dineshkumar T, Dhanapriya J, Malathy N, Haris M, Prasad ND. IgG4 related interstitial nephritis: A case report and review of literature. Indian J Nephrol 2013;23:308-11. [PMID: 23960352 DOI: 10.4103/0971-4065.114489] [Reference Citation Analysis]
124 Fong WWS, Thumboo J, Azhar R, Yoong JKC. IgG4-related disease in Singapore: a description of two cases and review of the literature. Int J Rheum Dis 2013;16:93-7. [DOI: 10.1111/1756-185x.12027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
125 Waheed W, Nickerson J, Ambaye AB, Babi MA, Tandan R. IgG4-Related Neuromyopathy Associated With Recurrent Pleural Effusion. J Clin Neuromuscul Dis 2015;16:210-9. [PMID: 25996967 DOI: 10.1097/CND.0000000000000066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
126 Maruyama M, Watanabe T, Kanai K, Oguchi T, Asano J, Ito T, Ozaki Y, Muraki T, Hamano H, Arakura N. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis. 2014;9:77. [PMID: 24884922 DOI: 10.1186/1750-1172-9-77] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
127 Kuruma S, Kamisawa T, Tabata T, Hara S, Fujiwara T, Kuwata G, Egarashira H, Koizumi K, Setoguchi K, Fujiwara J. Clinical Characteristics of Patients with Autoimmune Pancreatitis with or without Mikulicz's Disease and Mikulicz's Disease Alone. Gut Liver. 2013;7:96-99. [PMID: 23422705 DOI: 10.5009/gnl.2013.7.1.96] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
128 Mizushima I, Inoue D, Yamamoto M, Yamada K, Saeki T, Ubara Y, Matsui S, Masaki Y, Wada T, Kasashima S, Harada K, Takahashi H, Notohara K, Nakanuma Y, Umehara H, Yamagishi M, Kawano M. Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther 2014;16:R156. [PMID: 25056443 DOI: 10.1186/ar4671] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
129 Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S, Nishiyama T, Suda K, Shiratori K, Tanaka M, Shimosegawa T; The Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2014;49:567-88. [DOI: 10.1007/s00535-014-0942-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
130 Shao Y, Wang Z, Cao N, Shi H, Xie L, Fu J, Zheng L, Yu C. Prediction of 3-month treatment outcome of IgG4-DS based on BP artificial neural network. Oral Dis 2021;27:934-41. [PMID: 32790939 DOI: 10.1111/odi.13601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401-409. [PMID: 20548323 DOI: 10.1038/nrgastro.2010.81] [Cited by in Crossref: 154] [Cited by in F6Publishing: 121] [Article Influence: 12.8] [Reference Citation Analysis]
132 Kamisawa T, Takeuchi T. Treatment of autoimmune pancreatitis with the anecdotes of the first report. Int J Rheumatol 2012;2012:597643. [PMID: 22548071 DOI: 10.1155/2012/597643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
133 Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: A systematic review. Medicine (Baltimore) 2016;95:e4002. [PMID: 27368010 DOI: 10.1097/MD.0000000000004002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 31] [Article Influence: 13.2] [Reference Citation Analysis]
134 Lee JR, Lee B, Chung Y. Three Cases of IgG4-Related Sclerosing Disease in Nasal Cavity. J Rhinol 2016;23:44. [DOI: 10.18787/jr.2016.23.1.44] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Uchida K, Kusuda T, Koyabu M, Miyoshi H, Fukata N, Sumimoto K, Fukui Y, Sakaguchi Y, Ikeura T, Shimatani M. Regulatory T cells in type 1 autoimmune pancreatitis. Int J Rheumatol. 2012;2012:795026. [PMID: 22536257 DOI: 10.1155/2012/795026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
136 Wu Q, Chang J, Chen H, Chen Y, Yang H, Fei Y, Zhang P, Zeng X, Zhang F, Zhang W. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. Int J Rheum Dis 2017;20:639-46. [DOI: 10.1111/1756-185x.13088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
137 Yanagi H, Yamazaki I, Shimizu S, Himeno H, Suzuki S, Masuda M. Constrictive Pericarditis Caused by Immunoglobulin G4–Related Disease. The Annals of Thoracic Surgery 2014;97:e71-4. [DOI: 10.1016/j.athoracsur.2013.10.085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
138 Urabe Y, Fujii T, Kurushima S, Tsujiyama S, Kihara Y. Pigs-in-a-Blanket Coronary Arteries: A Case of Immunoglobulin G4-Related Coronary Periarteritis Assessed by Computed Tomography Coronary Angiography, Intravascular Ultrasound, and Positron Emission Tomography. Circ: Cardiovascular Imaging 2012;5:685-7. [DOI: 10.1161/circimaging.112.975946] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
139 Nikolic S, Panic N, Hintikka ES, Dani L, Rutkowski W, Hedström A, Steiner C, Löhr JM, Vujasinovic M. Efficacy and safety of rituximab in autoimmune pancreatitis type 1: our experiences and systematic review of the literature. Scand J Gastroenterol 2021;56:1355-62. [PMID: 34410885 DOI: 10.1080/00365521.2021.1963837] [Reference Citation Analysis]
140 Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Mod Pathol 2018;31:890-9. [PMID: 29434340 DOI: 10.1038/s41379-018-0036-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
141 Miyabe K, Notohara K, Nakazawa T, Hayashi K, Naitoh I, Okumura F, Shimizu S, Yoshida M, Yamashita H, Takahashi S, Ohara H, Joh T. Histological evaluation of obliterative phlebitis for the diagnosis of autoimmune pancreatitis. J Gastroenterol 2014;49:715-26. [DOI: 10.1007/s00535-013-0818-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
142 Hsu WL, Chang SM, Wu PY, Chang CC. Localized autoimmune pancreatitis mimicking pancreatic cancer: Case report and literature review. J Int Med Res. 2018;46:1657-1665. [PMID: 29332510 DOI: 10.1177/0300060517742303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
143 Kamisawa T, Takuma K, Tabata T, Inaba Y, Egawa N, Tsuruta K, Hishima T, Sasaki T, Itoi T. Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol. 2011;46:108-116. [PMID: 20824290 DOI: 10.1007/s00535-010-0317-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
144 Wolfson AR, Hamilos DL. Recent advances in understanding and managing IgG4-related disease. F1000Res 2017;6:F1000 Faculty Rev-185. [PMID: 28299186 DOI: 10.12688/f1000research.9399.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
145 Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, Teramoto A, Morita A. A Case of IgG4-Related Hypophysitis Without Pituitary Insufficiency. The Journal of Clinical Endocrinology & Metabolism 2013;98:1808-11. [DOI: 10.1210/jc.2013-1088] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
146 Tytgat GN. Autoimmune pancreatitis: a novel disease? J Dig Dis 2012;13:243. [PMID: 22500785 DOI: 10.1111/j.1751-2980.2012.00586.x] [Reference Citation Analysis]
147 Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, Dagna L, Praderio L, Scotti R, Tresoldi M, Roveri L, Mariani A, Balzano G, Castoldi R, Doglioni C, Sabbadini MG, Della-Torre E. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135-145. [PMID: 26398142 DOI: 10.3109/03009742.2015.1055796] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
148 Miyamoto Y, Kamisawa T, Tabata T, Hara S, Kuruma S, Chiba K, Inaba Y, Kuwata G, Fujiwara T, Egashira H. Short and long-term outcomes of diabetes mellitus in patients with autoimmune pancreatitis after steroid therapy. Gut Liver. 2012;6:501-504. [PMID: 23170157 DOI: 10.5009/gnl.2012.6.4.501] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
149 Kubota N, Ozaki K, Hoyano M, Okubo T, Kimura S, Yanagawa T, Kashimura T, Inomata T. Improvement of Mass Lesions around Coronary Arteries and Fractional Flow Reserve after Steroid Therapy in Immunoglobulin-G4-related Coronary Periarteritis. Intern Med 2022;61:351-6. [PMID: 35110514 DOI: 10.2169/internalmedicine.7880-21] [Reference Citation Analysis]
150 Kawasaki M, Tsujino M, Sato F, Sakurada M, Nishida K, Kise T, Hijioka Y, Ishizawa M, Enatsu K, Ogawa Y. IgG4-related Hypophysitis with Subtle Hypopituitarism in an Elderly Diabetic Patient: Is Treatment or Observation Preferable? Intern Med 2017;56:2733-8. [PMID: 28924128 DOI: 10.2169/internalmedicine.8851-17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
151 Xu C, Han Y. Immunoglobulin G4-related sclerosing cholangitis mimicking cholangiocarcinoma: a case report and literature review. J Int Med Res 2020;48:300060520959214. [PMID: 33025818 DOI: 10.1177/0300060520959214] [Reference Citation Analysis]
152 Sugimoto M, Takagi T, Suzuki R, Konno N, Watanabe K, Nakamura J, Kikuchi H, Waragai Y, Asama H, Takasumi M, Hikichi T, Watanabe H, Obara K, Ohira H. Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study. PLoS One 2015;10:e0138604. [PMID: 26381760 DOI: 10.1371/journal.pone.0138604] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
153 Kubota K, Watanabe S, Uchiyama T, Kato S, Sekino Y, Suzuki K, Mawatari H, Iida H, Endo H, Fujita K, Yoneda M, Takahashi H, Kirikoshi H, Kobayashi N, Saito S, Sugimori K, Hisatomi K, Matsuhashi N, Sato H, Tanida E, Sakaguchi T, Fujisawa N, Nakajima A. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol 2011;46:834-42. [DOI: 10.1007/s00535-011-0393-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
154 Hamano H, Tanaka E, Ishizaka N, Kawa S. IgG4-related Disease - A Systemic Disease that Deserves Attention Regardless of One's Subspecialty. Intern Med 2018;57:1201-7. [PMID: 29279491 DOI: 10.2169/internalmedicine.9533-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
155 Chen BN. IgG4-related disease presenting with destructive sinonasal lesion mimicking malignancy. Eur Arch Otorhinolaryngol 2016;273:4027-9. [PMID: 27056197 DOI: 10.1007/s00405-016-4033-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
156 Ohno Y, Kumagi T, Yokota T, Azemoto N, Tanaka Y, Tange K, Inada N, Miyata H, Imamura Y, Koizumi M, Kuroda T, Hiasa Y; EPOCH Study Group. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids. Orphanet J Rare Dis 2016;11:103. [PMID: 27465035 DOI: 10.1186/s13023-016-0487-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
157 Rodriguez EA, Williams FK. A mass in the junction of the body and tail of the pancreas with negative IgG4 serology: IgG4-related disease with negative serology. Am J Case Rep 2015;16:305-9. [PMID: 26001036 DOI: 10.12659/AJCR.893300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]